J L Donovan

1.8k total citations
27 papers, 1.2k citations indexed

About

J L Donovan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, J L Donovan has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in J L Donovan's work include Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). J L Donovan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). J L Donovan collaborates with scholars based in United Kingdom and United States. J L Donovan's co-authors include Katie Featherstone, Matthias Egger, Caroline Sanders, Stephen Frankel, Debbie Tallon, Joanna Coast, David Gillatt, Ashton Faulkner, J. Athene Lane and Liam Murray and has published in prestigious journals such as The Lancet, BMJ and The Journal of Urology.

In The Last Decade

J L Donovan

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J L Donovan United Kingdom 16 279 250 246 217 195 27 1.2k
Meredith Wallace United States 13 308 1.1× 150 0.6× 137 0.6× 266 1.2× 82 0.4× 23 1.2k
J Bryant United Kingdom 20 95 0.3× 253 1.0× 244 1.0× 119 0.5× 193 1.0× 32 1.4k
Lazaros Andronis United Kingdom 17 210 0.8× 166 0.7× 264 1.1× 118 0.5× 173 0.9× 57 1.1k
Julia Wade United Kingdom 16 196 0.7× 311 1.2× 180 0.7× 270 1.2× 134 0.7× 43 936
Anthony Roman United States 13 580 2.1× 137 0.5× 220 0.9× 207 1.0× 144 0.7× 30 1.3k
Rhiannon Macefield United Kingdom 17 245 0.9× 220 0.9× 501 2.0× 104 0.5× 142 0.7× 57 1.1k
Oscar Bortolami Italy 15 110 0.4× 202 0.8× 128 0.5× 130 0.6× 110 0.6× 30 1.0k
Kristina Laugesen Denmark 13 160 0.6× 230 0.9× 258 1.0× 189 0.9× 99 0.5× 39 1.7k
Patricia A. English United States 14 190 0.7× 126 0.5× 92 0.4× 345 1.6× 230 1.2× 24 1.3k
Itziar Etxeandia‐Ikobaltzeta United States 18 98 0.4× 233 0.9× 157 0.6× 132 0.6× 170 0.9× 32 1.1k

Countries citing papers authored by J L Donovan

Since Specialization
Citations

This map shows the geographic impact of J L Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J L Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J L Donovan more than expected).

Fields of papers citing papers by J L Donovan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J L Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J L Donovan. The network helps show where J L Donovan may publish in the future.

Co-authorship network of co-authors of J L Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of J L Donovan. A scholar is included among the top collaborators of J L Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J L Donovan. J L Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lane, J. Athene, SE Oliver, P Appleby, et al.. (2016). Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries. European Journal of Clinical Nutrition. 71(2). 274–283. 28 indexed citations
2.
Hill, Edward M., Richard M. Martin, Chris Metcalfe, et al.. (2015). Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - Lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer) Data collection, quality, and reporting. BMC Medical Research Methodology. 15. 2 indexed citations
3.
Chamberlain, Charlotte, Simon M. Collin, Peter Stephens, et al.. (2014). Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales. British Journal of Cancer. 111(9). 1693–1702. 18 indexed citations
4.
Owen‐Smith, Amanda, et al.. (2013). A NICE example? Variation in provision of bariatric surgery in England. BMJ. 346(may01 3). f2453–f2453. 26 indexed citations
5.
6.
Lane, J. Athene, Liam Murray, I M Harvey, et al.. (2011). Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Alimentary Pharmacology & Therapeutics. 33(8). 922–929. 86 indexed citations
7.
Dimitropoulou, Polyxeni, Richard M. Martin, Emma L. Turner, et al.. (2011). Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study. British Journal of Cancer. 104(5). 875–881. 19 indexed citations
8.
Harvey, Richard F., J. Athene Lane, Prakash Nair, et al.. (2010). Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations – the Bristol Helicobacter Project. Alimentary Pharmacology & Therapeutics. 32(3). 394–400. 44 indexed citations
9.
Lane, J. Athene, J L Donovan, David E. Neal, Freddie C. Hamdy, & Vishal S. Patil. (2009). The ProtecT trial: evaluating the effectiveness of treatments for clinically localised prostate cancer. European Urology Supplements. 8. 361–361. 1 indexed citations
10.
Metcalfe, Chris, Kate Tilling, Mark Davis, et al.. (2009). Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study. British Journal of Cancer. 101(3). 390–394. 16 indexed citations
11.
Lane, J. Athene, et al.. (2004). The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297). British Journal of Cancer. 91. 4 indexed citations
12.
Oliver, Steven, Kieran Jefferson, David Gunnell, et al.. (2003). IGF-axis and screen-detected prostate cancer: A cross-sectional study. The Journal of Urology. 169. 161–161. 1 indexed citations
13.
Gunnell, David, Steven Oliver, J L Donovan, et al.. (2002). Are diet-prostate cancer associations mediated by insulin-like growth factors? Cross-sectional analysis of diet-IGF associations in middle-aged men. Cancer Epidemiology Biomarkers & Prevention. 11.
14.
Valabhji, Jonathan, J L Donovan, P. Kyd, Michael Schächter, & R. S. Elkeles. (2001). The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabetic Medicine. 18(6). 451–458. 8 indexed citations
15.
Harvey, R.F., J. Athene Lane, Liam Murray, et al.. (2001). Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study. BMJ. 323(7307). 264.1–265. 22 indexed citations
16.
17.
18.
Sanders, Caroline, Matthias Egger, J L Donovan, Debbie Tallon, & Stephen Frankel. (1998). Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 317(7167). 1191–1194. 229 indexed citations
19.
Featherstone, Katie & J L Donovan. (1998). Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ. 317(7167). 1177–1180. 187 indexed citations
20.
Donovan, J L, et al.. (1997). Diagnosis, management and screening of early localised prostate cancer.. PubMed. 1(2). i, 1–96. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meredith Wallace Breakdown of academic impact, for papers by J Bryant Breakdown of academic impact, for papers by Lazaros Andronis Breakdown of academic impact, for papers by Julia Wade Breakdown of academic impact, for papers by Anthony Roman Breakdown of academic impact, for papers by Rhiannon Macefield Breakdown of academic impact, for papers by Oscar Bortolami Breakdown of academic impact, for papers by Kristina Laugesen Breakdown of academic impact, for papers by Patricia A. English Breakdown of academic impact, for papers by Itziar Etxeandia‐Ikobaltzeta
Rankless by CCL
2026